CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
7.52
-0.15 (-1.96%)
At close: Aug 29, 2025, 4:00 PM
7.50
-0.02 (-0.27%)
After-hours: Aug 29, 2025, 7:48 PM EDT

CERO Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.33.251.520.481.1
Cash & Short-Term Investments
3.33.251.520.481.1
Cash Growth
-9.44%113.76%219.73%-56.68%-
Prepaid Expenses
0.440.270.370.230.26
Restricted Cash
-0.070.0841.67-
Other Current Assets
0.50.11---
Total Current Assets
4.253.711.9742.371.36
Property, Plant & Equipment
1.461.993.16--
Long-Term Deferred Tax Assets
----0.02
Long-Term Deferred Charges
0.50.5---
Other Long-Term Assets
----178.7
Total Assets
6.26.215.1342.37180.08
Accounts Payable
6.214.511.671.650.01
Accrued Expenses
0.371.910.1400.08
Short-Term Debt
--0.60.65-
Current Portion of Leases
0.930.880.77--
Current Income Taxes Payable
---0.6-
Other Current Liabilities
0.110.110.3227.84-
Total Current Liabilities
7.627.43.5130.750.1
Long-Term Leases
0.220.71.58--
Other Long-Term Liabilities
---22.62187.65
Total Liabilities
7.848.15.0853.37187.75
Common Stock
00000
Additional Paid-In Capital
71.3167.141.03--
Retained Earnings
-81.44-70.92-43.09-11-7.67
Comprehensive Income & Other
-0.08-1.3---
Total Common Equity
-10.21-5.07-42.06-11-7.67
Shareholders' Equity
-1.63-1.890.04-11-7.67
Total Liabilities & Equity
6.26.215.1342.37180.08
Total Debt
1.151.582.940.65-
Net Cash (Debt)
2.151.68-1.42-0.171.1
Net Cash Per Share
1.8065.70--15.48-
Filing Date Shares Outstanding
1.210.27--0.01
Total Common Shares Outstanding
1.190.12--0.01
Working Capital
-3.37-3.69-1.5411.621.26
Book Value Per Share
-8.54-41.98---667.47
Tangible Book Value
-10.21-5.07-42.06-11-7.67
Tangible Book Value Per Share
-8.54-41.98---667.47
Machinery
2.552.552.55--
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q